Yahoo Web Search

Search results

    • Q2 2024 Outlook Therapeutics Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 1 day ago

      Participants Jenene Thomas; IR Contact Officer; Outlook Therapeutics Inc C. Russell Trenary; President, Chief Executive Officer, Director; Outlook Therapeutics ...

    • Canaan Inc. (CAN) Tops Q4 EPS by 4c, provides outlook

      StreetInsider· 2 hours ago

      Canaan Inc. (NASDAQ: CAN) reported Q4 EPS of ($0.16), $0.04 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $35.1 million versus the consensus estimate of $30.25 ...